9EVN
Plasmodium falciparum apical membrane antigen FVO
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ESRF BEAMLINE ID23-2 |
Synchrotron site | ESRF |
Beamline | ID23-2 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2012-05-01 |
Detector | MARMOSAIC 225 mm CCD |
Wavelength(s) | 0.8726 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 38.276, 94.216, 96.202 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 47.110 - 2.000 |
R-factor | 0.17889 |
Rwork | 0.177 |
R-free | 0.21890 |
Structure solution method | MOLECULAR REPLACEMENT |
RMSD bond length | 0.009 |
RMSD bond angle | 1.467 |
Data reduction software | XDS |
Data scaling software | Aimless |
Phasing software | PHASER |
Refinement software | REFMAC (5.8.0415) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 47.110 | 2.050 |
High resolution limit [Å] | 2.000 | 2.000 |
Number of reflections | 24245 | 1754 |
<I/σ(I)> | 8.1 | |
Completeness [%] | 99.8 | |
Redundancy | 3.6 | |
CC(1/2) | 0.994 | 0.491 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 290 | Crystals of PfAMA1-FVO were obtained by mixing 1 micro-L of protein and 1 micro-L of reservoir buffer containing 35 % PEG 5000 monomethylether, 0.1M Tris pH 8.5 and 0.2M Li2SO4. The final protein concentration was 3.5 mg/ml. Cryo-protecting buffer for PfAMA1-FVO crystals consisted of the crystallisation buffer with 15% of glycerol (v/v). |